Human monocyte scavenger receptors are pattern recognition receptors for (1→3)-β-D-glucans

Journal of Leukocyte Biology

Volumn 72, Issue 1, 2002, Pages 140-146

  Rice, Peter J ^a   Kelley, Jim L ^a   Kogan, Grigorij ^a,c   Ensley, Harry E ^b   Kalbfleisch, John H ^a   William Browder, I ^a,d   Williams, David L ^a,d  

^a EAST TENNESSEE STATE UNIVERSITY   (United States)

^b Tulane University   (United States)

^c INSTITUTE OF CHEMISTRY   (Slovakia)

^d James H Quillen VA Medical Center   (United States)

Author keywords

Acetylated LDL; Binding; Macrophage; Surface plasmon resonance

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; BETA GLUCAN; CELL RECEPTOR; LAMINARAN; POLYCYTIDYLIC ACID; POLYINOSINIC ACID;

ARTICLE; BINDING SITE; BIOSENSOR; CELL ADHESION; CELL WALL; CONTROLLED STUDY; HUMAN; HUMAN CELL; MACROPHAGE ACTIVATION; MOLECULAR RECOGNITION; MONOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SCAVENGING SYSTEM; SURFACE PLASMON RESONANCE;

BETA-GLUCANS; BINDING SITES; BINDING, COMPETITIVE; CARBOXYMETHYLCELLULOSE; CELL ADHESION MOLECULES; CELL MEMBRANE; GLUCANS; HUMANS; LIPOPROTEINS, LDL; MONOCYTES; POLY C; POLY I; POLYSACCHARIDES; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LDL; RECEPTORS, SCAVENGER; SIZOFIRAN; U937 CELLS;

FUNGI;

EID: 0036658734     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Modlin, R. L., Brightbill, H. D., Godowski, P. J. (2000) The Toll of innate immunity on microbial pathogens. N. Engl. J. Med. 340, 1834-1835.
2. Bendelac, A., Fearon, D. T. (2000) Innate immunity receptors and effectors of innate immunity. Curr. Opin. Immunol. 12, 11-12.
3. Krieger, M. (1997) The other side of scavenger receptors: pattern recognition for host defense. Curr. Opin. Lipidol. 8, 275-280.
4. Pearson, A. M. (1996) Scavenger receptors in innate immunity. Curr. Opin. Immunol. 8, 20-28.
5. Medzhitov, R., Janeway Jr., C. (2000) Innate immunity. N. Engl. J. Med. 343, 338-344.
6. Peiser, L., Gordon, S. (2001) The function of scavenger receptors expressed by macrophages and their role in the regulation of inflammation. Microbes Infect. 3, 149-159.
7. Linehan, S. A., Martinez-Pomares, L., Gordon, S. (2000) Mannose receptor and scavenger receptor: two macrophage pattern recognition receptors with diverse functions in tissue homeostatis and host defense. Adv. Exp. Med. Biol. 479, 1-14.
8. Williams, D. L., Pretus, H. A., Browder, I. W. (1992) Application of aqueous gel permeation chromatography with in-line multi-angle laser light scattering and differential viscometry detectors for the characterization of natural product carbohydrate pharmaceuticals. J. Liq. Chromatogr. 15, 2297-2309.
9. Mueller, A., Rice, P. J., Ensley, H. E., Coogan, P. S., Kalbfleisch, J. H., Kelley, J. L., Love, E. J., Portera, C. A., Ha, T., Browder, I. W., Williams, D. L. (1996) Receptor binding and internalization of water-soluble (1→3)-beta-D-glucan biologic response modifier in two monocyte/macrophage cell lines. J. Immunol. 156, 3418-3425.
10. Williams, D. L., Mueller, A., Browder, W. (1996) Glucan-based macrophage stimulators: a review of their anti-infective potential. Clin. Immunother. 5, 392-399.
11. Czop, J. K., Kay, J. (1991) Isolation and characterization of β-glucan receptors on human mononuclear phagocytes. J. Exp. Med. 173, 1511-1520.
12. Thornton, B. P., Vetvicka, V., Pitman, M., Goldman, R. C., Ross, G. D. (1996) Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J. Immunol. 156, 1235-1246.
13. Vetvicka, V., Thornton, B. P., Ross, G. D. (1996) Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells. J. Clin. Investig. 98, 50-61.
14. Ohno, N., Miura, N. N., Chiba, N., Adachi, Y., Yadomae, T. (1995) Comparison of the immunopharmacological activities of triple and singlehelical schizophyllan in mice. Biol. Pharm. Bull. 18, 1242-1247.
15. Vetvicka, V., Thornton, B. P., Wieman, J., Ross, G. D. (1997) Targeting of natural killer cells to mammary carcinoma via naturally occurring tumor cell-bound iC3b and beta-glucan-primed CR3. J. Immunol. 159, 599-605.
16. Itoh, W. (1997) Augmentation of protective immune responses against viral infection by oral administration of schizophyllan. Mediators Inflamm. 6, 267-269.
17. Zimmerman, J. W., Lindermuth, J., Fish, P. A., Palace, G. P., Stevenson, T. T., DeMong, D. E. (1998) A novel carbohydrate-glycosphingolipid interaction between a beta-(1→3)-glucan immunomodulator, PGG-glucan, and lactosylceramide of human leukocytes. J. Biol. Chem. 273, 22014-22020.
18. Wakshull, E., Brunke-Reese, D., Lindermuth, J., Fisette, L., Nathans, R. S., Crowley, J. J., Tufts, J. C., Zimmerman, J., Mackin, W., Adams, D. S. (1999) PGG-glucan, a soluble beta-(1,3)-glucan, enhances the oxidative burst response, microbicidal activity, and activates an NF-kappaB-like factor in human PMN: evidence for a glycosphingolipid beta-(1,3)glucan receptor. Immunopharmacology 41, 89-107.
19. Mueller, A., Raptis, J., Rice, P. J., Kalbfleisch, J. H., Stout, R. D., Ensley, H. E., Browder, W., Williams, D. L. (2000) The influence of glucan polymer structure and solution conformation on binding to (1→3)-β-D-glucan receptors in a human monocyte-like cell line. Glycobiology 10, 339-346.
20. Obayashi, T., Yoshida, M., Mori, T., Goto, H., Yasuoka, A., Iwasaki, H., Teshima, H., Kohno, S., Horiuchi, A., Ito, A., et al. (1995) Plasma (1→3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 345, 17-20.
21. Miyazaki, T., Kohno, S., Mitsutake, K., Maesaki, S., Tanaka, K., Ishikawa, N., Hara, K. (1995) Plasma (1→3)-beta-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis. J. Clin. Microbiol. 33, 3115-3118.
22. Mori, T., Ikemoto, H., Matsumura, M., Yoshida, M., Inada, K., Endo, S., Ito, A., Watanabe, S., Yamaguchi, H., Mitsuya, M., Kodama, M., Tani, T., Yokota, T., Kobayashi, T., Kambayashi, J., Nakamura, T., Masaoka, T., Teshima, H., Yoshinaga, T., Kohno, S., Hara, K., Miyazaki, S. (1997) Evaluation of plasma (1→3)-beta-D-glucan measurement by the kinetic turbidimetric Limulus test, for the clinical diagnosis of mycotic infections. Eur. J. Clin. Chem. Biochem. 35, 553-560.
23. Hiyoshi, M., Tagawa, S., Hashimoto, S., Sakamoto, C., Tatsumi, N. (1999) Evaluation of a new laboratory test measuring plasma (1→3)-β-D-glucan in the diagnosis of Candida deep mycosis: comparison with a serologic test. Kansenshogaku Zasshi 73, 1-6.
24. Janeway Jr., C. A., Medzhitov, R. (1999) Lipoproteins take their Toll on the host. Curr. Biol. 9, R879-R882.
25. Michalek, M., Melican, D., Brunke-Reese, D., Langevin, M., Lemerise, K., Galbraith, W., Patchen, M., Mackin, W. (1998) Activation of rat macrophages by Betafectin PGG-glucan requires cross-linking of membrane receptors distinct from complement receptor three (CR3). J. Leukoc. Biol. 64, 337-344.
26. Brown, G. D., Gordon, S. (2001) Immune recognition. A new receptor for beta-glucans. Nature 413, 36-37.
27. Kougias, P., Wei, D., Rice, P. J., Ensley, H. E., Kalbfleisch, J., Williams, D. L., Browder, I. W. (2001) Normal human fibroblasts express pattern recognition receptors for fungal (1→3)-β-D-glucans. Infect. Immun. 69, 3933-3938.
28. Dushkin, M. I., Safina, A. F., Vereschagin, E. I., Schwartz, Y. S. (1996) Carboxymethylated beta-1,3-glucan inhibits the binding and degradation of acetylated low density lipoproteins in macrophages in vitro and modulates their plasma clearance in vivo. Cell Biochem. Funct. 14, 209-217.
29. Vereschagin, E. I., Van Lambalgen, A. A., Dushkin, M. I., Schwartz, Y. S., Polyakov, L., Heemskerk, A., Huisman, E., Thijs, L. G., Van den Bos, G. C. (1998) Soluble glucan protects against endotoxin shock in the rat: the role of the scavenger receptor. Shock 9, 193-198.
30. Pearson, A., Lux, A., Kreieger, M. (1995) Expression cloning of dSR-CI, a class C macrophage-specific scavenger receptor from Drosophila melanogaster. Proc. Natl. Acad. Sci. USA 92, 4056-4060.
31. Goldstein, J. L., Ho, Y. K., Basu, S. K., Brown, M. S. (1979) Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA 76, 333-337.
32. Brown, M. S., Goldstein, J. L. (1983) Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 52, 223-261.
33. Dejager, S., Mietus-Snyder, M., Pitas, R. E. (1993) Oxidized low density lipoproteins bind to the scavenger receptor expressed by rabbit smooth muscle cells and macrophages. Arterioscler. Thromb. Vasc. Biol. 13, 371-378.
34. Steinberg, D. (1995) Role of oxidized LDL and antioxidants in atherosclerosis. Adv. Exp. Med. Biol. 369, 39-48.
35. Kelley, J. L. (1991) Macrophage scavenger receptor(s) for modified low density lipoproteins. Prog. Lipid Res. 30, 231-235.
36. Gough, P. J., Gordon, S. (2000) The role of scavenger receptors in the innate immune system. Microbes Infect. 2, 305-311.
37. Thomas, C. A., Li, Y., Kodama, T., Suzuki, H., Silverstein, S. C., El Khoury, J. (2000) Protection from lethal gram-positive infection by macrophage scavenger receptor-dependent phagcytosis. J. Exp. Med. 191, 147-156.
38. Williams, D. L., McNamee, R. B., Jones, E. L., Pretus, H. A., Ensley, H. E., Browder, I. W., Di Luzio, N. R. (1991) A method for the solubilization of a (1→3)-β-D-glucan isolated from Saccharomyces cerevisiae. Carbohydr. Res. 219, 203-213.
39. Machova, E., Kogan, G., Alfoldi, J., Soltes, L., Sandula, J. (1995) Enzymatic and ultrasonic depolymerization of carboxymethylated β-1,3-D-glucans derived from Saccharomyces cerevisiae. J. Appl. Polym. Sci. 55, 699-704.
40. Zülli, F., Saecker, C. (1994) CM-glucan a new yeast polysaccharide for cosmetic use. Cosmetic and Toiletry Manufacturing World, 131-136.
41. Ensley, H. E., Tobias, B., Pretus, H. A., McNamee, R. B., Jones, E. L., Browder, I. W., Williams, D. L. (1994) NMR spectral analysis of a water-insoluble (1→3)-β-D-glucan isolated from Saccharomyces cerevisiae. Carbohydr. Res. 258, 307-311.
42. Mueller, A., Pretus, H., McNamee, R., Jones, E., Browder, I., Williams, D. (1995) Comparison of the carbohydrate, biological response modifiers Krestin, schizophyllan and glucan phosphate by aqueous size exclusion chromatographty with in-line argon-ion multi-angle laser light scattering photometry and differential viscometry detectors. J. Chromatogr. 666, 283-290.
43. Sandula, J., Kogan, G., Kacurakova, M., Machova, E. (1999) Microbial (1→3)-β-D-glucans, their preparation, physicochemical characterization and immunomodulatory activity. Carbohydr. Polym. 38, 247-253.
44. Kogan, G. (2000) (1-3, 1-6)-β-D-Glucans of yeasts and fungi and their biological activity. In Studies in Natural Products Chemistry 23, Part D (A.U. Rahman, ed.). Elsevier Science, Amsterdam, 107-152.
45. Lowman, D., Ensley, H., Williams, D. (1998) Identification of phosphate substitution sites by NMR spectroscopy in a water-soluble phosphorylated (1→3)-β-D-glucan. Carbohydr. Res. 306, 559-562.
46. Kelley, J. L., Rozek, M. M., Suenram, C. A., Schwartz, C. J. (1988) Activation of human peripheral blood monocytes; by lipoproteins. Am. J. Pathol. 130, 223-231.
47. Brown, M. S., Goldstein, J. L., Krieger, M., Ho, Y. K., Anderson, R. G. W. (1979) Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins. J. Cell Biol. 82, 597-613.
48. Brown, M. S., Basu, S. K., Falck, J. R., Ho, Y. K., Goldstein, J. L. (1980) The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages. J. Supramol. Struct. 13, 67-81.
49. Sakagami, Y., Mizoguchi, Y., Shin, T., Seki, S., Kobayashi, K., Morisawa, S., Yamamoto, S. (1988) Effects of an anti-tumor polysaccharide, schizophyllan, on interferon-gamma and interleukin 2 production by peripheral blood mononuclear cells. Biochem. Biophys. Res. Commun. 155, 650-655.
50. Battle, J., Ha, T., Li, C., Della Beffa, V., Rice, P., Kalbfleisch, J., Browder, W., Williams, D. (1998) Ligand binding to the (1→3)-β-D-glucan receptor stimulates NF-kappaB activation, but not apoptosis in U937 cells. Biochem. Biophys. Res. Commun. 249, 499-504.
51. Lowe, E., Rice, P., Ha, T., Li, C., Kelley, J., Ensley, H., Lopez-Perez, J., Kalbfleisch, J., Lowman, D., Margl, P., Browder, W., Williams, D. (2001) A (1→3)-β-D-linked heptasaccharide is the unit ligand for glucan pattern recognition receptors on human monocytes. Microbes Infect. 3, 789-797.
52. Kougias, P., Wei, D., Rice, P. J., Ensley, H. E., Kalbfleisch, J., Williams, D. L., Browder, I. W. (2001) Normal human fibroblasts express pattern recognition receptors for fungal (1→3)-β-D-glucans. Infect. Immun. 69, 3933-3938.
53. Peiser, L., Gordon, S. (2001) The function of scavenger receptors expressed by macrophages and their role in the regulation of inflammation. Microbes Infect. 3, 149-159.
54. Hampton, R. Y., Golenbock, D. T., Penman, M., Krieger, M., Raetz, C. R. (1991) Recognition and plasma clearance of endotoxin by scavenger receptors. Infect. Immun. 64, 3318-3325.
55. Ashkenas, J., Penman, M., Vasile, E., Acton, S., Freeman, M., Krieger, M. (1993) Structures and high and low affinity ligand binding properties of murine type I and type II macrophage scavenger receptors. J. Lipid Res. 34, 983-1000.
56. Dunne, D. W., Resnick, D., Greenburg, J., Krieger, M., Joiner, K. A. (1994) The type 1 macrophage scavenger receptor binds to gram-positive bacteria and recognizes lipoteichoic acid. Proc. Natl. Acad. Sci. USA 91, 1863-1867.
57. Ahren, I. L., Williams, D. L., Rice, P. J., Forsgren, A., Riesbeck, K. (2001) The importance of a β-glucan receptor in the nonopsonic entry of nontypeable Haemophilus influenzae into human monocytic and epithelial cells. J. Infect. Dis. 184, 150-158.